Evidence map›Paper›PMID 20029340›Full record

ArticleCritical care medicine2010

Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.

Nancy Fathali, Robert P Ostrowski, Tim Lekic, Vikram Jadhav, Wenni Tong, Jiping Tang, John H Zhang

Open access · greenAbstract read
In one paragraph

Article in Critical care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nancy FathaliDepartment of Human Pathology and Anatomy, Loma Linda University, Loma Linda, CA, USA.
Robert P Ostrowski
Tim Lekic
Vikram Jadhav
Wenni Tong
Jiping Tang
John H Zhang
Loma Linda University · US

Funding

Mechanisms of EPO-Induced NeuroprotectionR01NS054685 · NINDS · LOMA LINDA UNIVERSITY · PI ZHANG, JOHN H · 2007 to 2011
$1.8M
Neurovirulence of murine coronavirus: roles of viral genesR01NS054695 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 2006 to 2010
$1.7M
Oxygen Therapy in Neonatal Hypoxia-IschemiaR01HD043120 · NICHD · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHANG, JOHN H. · 2003 to 2007
$1.6M
NICHD NIH HHS HD43120NICHD NIH HHS R01 HD043120NINDS NIH HHS NS54685NINDS NIH HHS R01 NS054685NINDS NIH HHS R01 NS054695
6 · The paper itself

Abstract

objectiveTo investigate whether inhibition of cyclooxygenase-2, a critical component of the inflammatory pathway, is neuroprotective in a neonatal rat model of cerebral hypoxia-ischemia. The development of brain inflammation largely contributes to neonatal brain injury that may lead to a lifetime of neurologic deficits.

designLaboratory investigation.

settingUniversity research laboratory. SUBJECTS: Postnatal day ten Sprague-Dawley rats.

interventionsNeonatal hypoxia-ischemia was induced by ligation of the right common carotid artery followed by 2 hrs of hypoxia (8% oxygen). The pups in treatment groups were administered 10 mg/kg (low dose) or 30 mg/kg (high dose) of a known selective cyclooxygenase-2 inhibitor (NS398). Animals were euthanized at three time points: 72 hrs, 2 wks, or 6 wks. Inflammation outcomes were assessed at 72 hrs; brain damage was assessed at 2 wks and 6 wks along with other organs (heart, spleen). Detailed neurobehavioral examination was performed at 6 wks. MEASUREMENTS AND MAIN

resultsPharmacologic inhibition of cyclooxygenase-2 markedly increased survivability within the first 72 hrs compared with untreated rats (100% vs. 72%). Low- and high-dose NS398 significantly attenuated the loss of brain and body weights observed after hypoxia-ischemia. Neurobehavioral outcomes were significantly improved in some parameters with low-dose treatment, whereas high-dose treatment consistently improved all neurologic deficits. Immunohistochemical results showed a marked decrease in macrophage, microglial, and neutrophil abundance in ipsilateral hemisphere of the NS398-treated group along with a reduction in interleukin-6 expression.

conclusionsSelective cyclooxygenase-2 inhibition protected neonatal rats against death, progression of brain injury, growth retardation, and neurobehavioral deficits after a hypoxic-ischemic insult.

Indexed as

AnimalsAnimals, NewbornBehavior, AnimalBlotting, WesternBody WeightBrainCyclooxygenase 2Cyclooxygenase 2 InhibitorsDose-Response Relationship, DrugHypoxia-Ischemia, BrainInflammationInterleukin-6Neuroprotective AgentsNitrobenzenesRatsRats, Sprague-DawleyCyclooxygenase 2Cyclooxygenase 2 InhibitorsInterleukin-6N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideNeuroprotective AgentsNitrobenzenesSulfonamides

Identifiers

PMID20029340
PMCPMC2808453
OpenAlexW1968869536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.